BriaCell Therapeutics Corp.
BCTXW · NASDAQ
7/31/2025 | 7/31/2024 | 7/31/2023 | 7/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $10 | $1 | $21 | $41 |
| Short-Term Investments | $7 | $0 | $0 | $0 |
| Receivables | $1 | $1 | $1 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $1 | $5 | $1 |
| Total Curr. Assets | $20 | $4 | $27 | $42 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $1 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $1 | $0 | $0 |
| Total NC Assets | $2 | $2 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $22 | $6 | $27 | $43 |
| Liabilities | – | – | – | – |
| Payables | $3 | $7 | $1 | $0 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1 | $0 | $1 | $0 |
| Total Curr. Liab. | $4 | $7 | $2 | $1 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $1 | $29 | $31 |
| Total NC Liab. | $0 | $1 | $29 | $31 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $4 | $9 | $31 | $32 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $102 | $72 | $70 | $66 |
| Retained Earnings | -$112 | -$85 | -$81 | -$60 |
| AOCI | $28 | -$0 | -$0 | -$0 |
| Other Equity | $0 | $11 | $33 | $25 |
| Total Equity | $18 | -$2 | -$4 | $10 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$1 | -$0 | $0 | $0 |
| Total Liab. & Tot. Equity | $22 | $6 | $27 | $43 |
| Net Debt | -$10 | -$1 | -$21 | -$41 |